Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jonathan Yamzon
Paclitaxel-Based High-Dose Chemotherapy With Autologous Stem Cell Rescue for Relapsed Germ Cell Tumor: Clinical Outcome and Quality of Life in Long-Term Survivors
Clinical Genitourinary Cancer
Oncology
Urology
Related publications
Cardiorespiratory Fitness in Long-Term Lymphoma Survivors After High-Dose Chemotherapy With Autologous Stem Cell Transplantation
British Journal of Cancer
Cancer Research
Oncology
Gonadal Failure Is Common in Long-Term Survivors of Childhood High-Risk Neuroblastoma Treated With High-Dose Chemotherapy and Autologous Stem Cell Rescue
Frontiers in Endocrinology
Endocrinology
Metabolism
Diabetes
High-Dose Chemotherapy and Autologous Stem Cell Rescue for Atypical Teratoid/Rhabd Tumor of the Central Nervous System
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Treatment of Poor-Risk Neuroblastoma Patients With High-Dose Chemotherapy and Autologous Peripheral Stem Cell Rescue
Bone Marrow Transplantation
Transplantation
Hematology
Reduced Sexual Function in Long-Term Male Lymphoma Survivors After High Dose Therapy With Autologous Stem Cell Transplantation
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Long-Term Event-Free Survivors After High-Dose Therapy and Autologous Stem-Cell Transplantation for Low-Grade Follicular Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
High-Dose Chemotherapy (HDC) and Autologous Hematopoietic Stem Cell Transplantation (ASCT) as Salvage Therapy for Relapsed Osteosarcoma
Bone Marrow Transplantation
Transplantation
Hematology
Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
High-Dose Chemotherapy With Carboplatin, Etoposide and Ifosfamide Followed by Autologous Stem Cell Rescue in Patients With Relapsed or Refractory Malignant Lymphomas: A Phase I/Ii Study
Bone Marrow Transplantation
Transplantation
Hematology
